(19)
(11) EP 1 624 908 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
15.06.2011 Bulletin 2011/24

(45) Mention of the grant of the patent:
05.01.2011 Bulletin 2011/01

(21) Application number: 04809390.0

(22) Date of filing: 19.05.2004
(51) International Patent Classification (IPC): 
A61L 31/14(2006.01)
 A61L 31/16(2006.01)
(86) International application number:
PCT/US2004/015846
(87) International publication number:
WO 2005/025634 (24.03.2005 Gazette 2005/12)

(54)

BIOINTERFACE MEMBRANES INCORPORATING BIOACTIVE AGENTS

BIOINTERFACE-MEMBRANEN MIT BIOAKTIVEN MITTELN

MEMBRANES DE BIO-INTERFACE INCORPORANT DES AGENTS BIOACTIFS

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30) Priority: 21.05.2003 US 472673 P
22.08.2003 US 647065
12.02.2004 US 544722 P

(43) Date of publication of application:
15.02.2006 Bulletin 2006/07

(73) Proprietor: DexCom, Inc.
San Diego CA 92121 (US)

(72) Inventors:
  • CARR-BRENDEL, Victoria
    Pleasanton, CA 94566 (US)
  • TAPSAK, Mark
    Orangeville, PA 17859 (US)
  • MARKOVIC, Dubravka
    San Diego, CA 92122 (US)
  • Shults, Mark
    Madison, WI 53705 (US)
  • Brauker, James H.
    San Diego, CA 92131 (US)

(74) Representative: Smaggasgale, Gillian Helen 
W.P. Thompson & Co 55 Drury Lane
London WC2B 5SQ
London WC2B 5SQ (GB)


(56) References cited: : 
US-A- 5 741 330
US-A1- 2002 133 224
 US-A- 5 837 728
US-A1- 2003 023 317
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).